ArticleTargeted oncology2023

First-in-Human Study of INCB062079, a Fibroblast Growth Factor Receptor 4 Inhibitor, in Patients with Advanced Solid Tumors.

James J Harding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.